Article
Performance of non‐invasive prenatal testing when fetal cell‐free <scp>DNA</scp> is absent
31 Oct 2014
Abstract excerpt
Numerous studies have validated the accuracy of non-invasive prenatal testing (NIPT) using fetal cell-free DNA (cfDNA) to assess the risk of fetal aneuploidies early in pregnancy1, and we have used this technology in our practice since 2012 in both low- and high-risk women2. We are aware that several factors influence the fraction of fetal cfDNA present in maternal blood. Such factors include gestational age and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
